Industry News
Identifying Patients With Increased Risk From Throat Cancer
Jan 18, 2012
Independent of other factors, such as smoking history and HPV status, matted lymph nodes appear to signal increased chance of oropharyngeal cancer spreading to other parts of the body Researchers at the University of Michigan Health System have found a new indicator that may predict which patients with a common type of throat cancer are most likely have the cancer spread to ... Read More
Researchers Identify Changes In Tumor Cells That Lead To Metastasis
Jan 18, 2012
Researchers at the Centro de Gen0mica e Investigaci0n Oncologica (GENYO) - of which the University of Granada, Pfizer and the Andalusian Regional Government are members - have identified the genetic and phenotypic changes that cause tumor progression and metastasis... Read More
A Protein May Trigger Spread Of Breast Cancer
Jan 18, 2012
Cancers rarely are deadly unless they evolve the ability to grow beyond the tissues in which they first arise. Normally, cells - even early-stage tumor cells - are tethered to scaffolding that helps to restrain any destructive tendencies... Read More
Declines In Melanoma Deaths Limited To The Most Educated
Jan 18, 2012
A new study from the American Cancer Society finds recent declines in melanoma mortality rates in non-Hispanic Whites in the U.S. mainly reflect declines in those with the highest level of education, and reveals a widening disparity in melanoma mortality rates by education... Read More
Identifying Patients With Increased Risk From Throat Cancer
Jan 18, 2012
Independent of other factors, such as smoking history and HPV status, matted lymph nodes appear to signal increased chance of oropharyngeal cancer spreading to other parts of the body Researchers at the University of Michigan Health System have found a new indicator that may predict which patients with a common type of throat cancer are most likely have the cancer spread to ... Read More
FDA Approves Voraxaze To Treat Patients With Chemotherapy Toxicity
Jan 17, 2012
Voraxaze is an enzyme that rapidly breaks down the chemotherapy drug methotrexate to a byproduct that the body can more easily eliminate. Voraxaze is given intravenously. Methotrexate was developed in the 1950s as a chemotherapy and is used either alone or in combination with other drugs... Read More
Analysis Examines Rate Of In-Hospital Blood Clots Following Hip Or Knee Replacement
Jan 17, 2012
According to a study in the January 18 issue of JAMA reveals, approximately 1 in every 100 patients undergoing knee replacement surgery and 1 in every 200 patients undergoing hip replacement surgery who use current preventive medications for venous thromboembolism (VTE; a blood clot that develops within a vein that might become serious), will develop VTE before being discharged from hospital... Read More
Drug Helps Maintain Platelet Inhibition And Anti-Clotting Levels Prior To Cardiac Surgery
Jan 17, 2012
According to a study in the January 18 issue of JAMA, patients who stop using an antiplatelet agent, such as clopidogrel before undergoing cardiac surgery to reduce their risk of bleeding and received intravenously the platelet inhibitor cangrelor achieved a higher rate of maintenance of platelet inhibition than those who were given placebo... Read More
Preoperative Breast Cancer Treatment May Be Improved By Combining 2 Anti-HER2 Drugs
Jan 17, 2012
Using two drugs that inhibit the growth factor HER2 for preoperative treatment of early-stage HER2-positive breast cancer appears to have better results than treatment with a single agent... Read More
Predicting The Value Of Indexing Symptoms For Ovarian Cancer
Jan 17, 2012
The use of symptom indices to identify patients with symptoms associated with ovarian cancer who may need further screening is increasing in both the UK and the US in an attempt to promote earlier diagnosis, but they may need to be reassessed in order to help better detect cancer, according to a study published January 13 in the Journal of the National Cancer Institute... Read More
Previous Page Next Page